Related Experiment Video
Updated: Nov 12, 2025

Author Spotlight: Developing a Microfluidic Lung-on-Chip Model for In-Depth Study of Human Immune Response and Infection Mechanisms
Published on: May 31, 2024
[Échinococcose alvéolaire].
Dominique Angèle Vuitton1, Georges Mantion1, Laurence Million1
1Université Bourgogne Franche-Comté, Besançon, France.
Alveolar echinococcosis, a parasitic liver disease, is increasingly diagnosed incidentally, even outside endemic areas. Advances have improved prognosis, but its changing epidemiology presents new diagnostic and management challenges.
Area of Science:
- Parasitology
- Hepatology
- Infectious Diseases
Background:
- Alveolar echinococcosis is a severe parasitic zoonosis mimicking liver cancer.
- It obstructs bile ducts and vessels, potentially metastasizing to distant organs.
- Historically, it had a poor prognosis, but recent advances have transformed outcomes.
Purpose of the Study:
- To highlight the evolving epidemiology of alveolar echinococcosis.
- To discuss the challenges in diagnosis and management due to changing patterns.
- To emphasize its emerging role as an opportunistic infection.
Main Methods:
- Review of recent epidemiological data and clinical case reports.
- Analysis of diagnostic imaging and treatment advancements.
- Assessment of the impact of immunosuppressive therapies.
Main Results:
- The endemic area for alveolar echinococcosis in Europe has significantly expanded.
- Case numbers have more than doubled in established endemic regions.
- The disease is increasingly diagnosed incidentally and in non-traditional populations, including immunocompromised patients.
Conclusions:
- Prognosis has improved due to earlier diagnosis and better treatments.
- Alveolar echinococcosis is now frequently an 'opportunistic infection'.
- The expanding range and atypical presentations complicate differential diagnosis and patient care.
More Related Videos
07:21Processing of Bronchoalveolar Lavage Fluid and Matched Blood for Alveolar Macrophage and CD4+ T-cell Immunophenotyping and HIV Reservoir Assessment
Published on: June 23, 2019
06:43Studying Microbial Communities In Vivo: A Model of Host-mediated Interaction Between Candida Albicans and Pseudomonas Aeruginosa in the Airways
Published on: January 13, 2016
Related Concept Videos
Alveoli and Alveolar Ducts
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...